EV/EBITDA
-4.06
-0.16-4.10%
7 min ago
Summary:
Pacific Biosciences of California EV/EBITDA is currently -4.06, with a fall of -0.16 (-4.10%) during the most recent trading day. Over the past year, it has increased by +5.95 (+59.44%). PACB EV/EBITDA is now -101.61% below its all-time high of 252.41.PACB EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PACB EV/EBITDA Performance
PeriodPeriod | EV/EBITDAEV/EBITDA |
---|---|
todaytoday | -4.1% |
3 m3 months | -19.1% |
6 m6 months | +21.6% |
1 y1 year | +59.4% |
5 y5 years | +48.7% |
PACB EV/EBITDA High & Low
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1 month | -3.78 | -7.4% | -4.06 | at low |
3 m | 3 months | -3.39 | -19.8% | -4.06 | at low |
6 m | 6 months | -3.27 | -24.2% | -5.32 | +23.7% |
1 y | 1 year | -3.27 | -24.2% | -10.01 | +59.4% |
3 y | 3 years | -3.27 | -24.2% | -50.15 | +91.9% |
5 y | 5 years | 252.41 | -101.6% | -150.79 | +97.3% |
alltime | all time | 252.41 | -101.6% | -150.79 | +97.3% |
Pacific Biosciences Of California EV/EBITDA History
Date | Value |
---|---|
2024 | -4.06(-53.7%) |
2022 | -8.77(-56.2%) |
2021 | -20.02(-115.8%) |
2020 | 126.97(-1209.9%) |
2019 | -11.44(-4.0%) |
2018 | -11.92(+217.0%) |
2017 | -3.76(-28.1%) |
Date | Value |
---|---|
2016 | -5.23(-87.3%) |
2015 | -41.11(+335.9%) |
2014 | -9.43(+101.1%) |
2013 | -4.69(+694.9%) |
2012 | -0.59(-37.9%) |
2011 | -0.95(-81.6%) |
2010 | -5.16 |
FAQ
- What is Pacific Biosciences of California EV/EBITDA?
- What is the all time high EV/EBITDA for Pacific Biosciences of California?
- What is Pacific Biosciences of California EV/EBITDA year-on-year change?
What is Pacific Biosciences of California EV/EBITDA?
The current EV/EBITDA of PACB is -4.06
What is the all time high EV/EBITDA for Pacific Biosciences of California?
Pacific Biosciences of California all-time high EV/EBITDA is 252.41
What is Pacific Biosciences of California EV/EBITDA year-on-year change?
Over the past year, PACB EV/EBITDA has changed by +5.95 (+59.44%)